FDA Issues Call For Data On Unreviewed OTCs To Complete Drug Review
This article was originally published in The Tan Sheet
Executive Summary
FDA is requesting information on whether urinary analgesic/antiseptic products are appropriate for self-medication in a call for data on a range of products eligible for the OTC drug review. The notice was published in the Federal Register Dec. 31
You may also be interested in...
FDA Proposes Aloe Vera, Other Ingredients For Non-GRASE List
FDA has proposed adding aloe vera products labeled for analgesic and antimicrobial uses to its list of ingredients and categories that lack adequate data to establish their safety and effectiveness
FDA Proposes Aloe Vera, Other Ingredients For Non-GRASE List
FDA has proposed adding aloe vera products labeled for analgesic and antimicrobial uses to its list of ingredients and categories that lack adequate data to establish their safety and effectiveness
FDA Proposes Aloe Vera, Other Ingredients For Non-GRASE List
FDA has proposed adding aloe vera products labeled for analgesic and antimicrobial uses to its list of ingredients and categories that lack adequate data to establish their safety and effectiveness